Acarbose in Insulin-Dependent Diabetes Mellitus: Efficacy and Tolerance

  • S. G. T. Hulst
  • P. F. J. M. Spooren
  • P. A. Smith
  • T. Hulk
Conference paper

Abstract

The effect of the α-glucosidase inhibitor acarbose on metabolic control was studied in insulin-dependent diabetics who were accustomed to home monitoring of blood glucose levels and to adapting their insulin dose. Following informed consent 20 patients took part in the 4-week run-in period under placebo treatment. Thereafter they were treated for 8 weeks with thrice-daily 100 mg acarbose po; this was followed by another 4-week placebo treatment.

Keywords

Placebo Odour Acarbose 

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • S. G. T. Hulst
    • 1
  • P. F. J. M. Spooren
    • 1
  • P. A. Smith
    • 1
  • T. Hulk
    • 1
  1. 1.Department of Internal Medficine, Biochemistry and DieteticsZiekenhuis “Ziekenzorg”EnschedeNetherlands

Personalised recommendations